On the right panel, the SPEDOX-6 treatment group tissue seems to show reduced cancer cell density and lower Ki67 but higher cleaved caspase-3 levels relative to the Doxil treatment panel, indicating better antitumor efficacy by SPEDOX-6 than Doxil, which is consistent with the tumor TV study. This evidence concerns the gene MKI67 and cancer.